Please login to the form below

Not currently logged in
Email:
Password:

Patent

This page shows the latest Patent news and features for those working in and with pharma, biotech and healthcare.

Sobi takes ownership of rare disease drug Gamifant for $518m

Sobi takes ownership of rare disease drug Gamifant for $518m

Fulfils rare disease firm's global expansion plans. Sobi has bought up the intellectual property and patents on Gamifant, the rare disease drug it had previously licensed from Novimmune, plus a ... As well as buying all IP, patent rights, data and

Latest news

More from news
Approximately 68 fully matching, plus 1,498 partially matching documents found.

Latest Intelligence

  • Combining therapies and combining research Combining therapies and combining research

    Wholly focused on the discovery and development of new antibiotic combinations, it has already registered 128 patents for novel combinations active against highly resistant bacteria.

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    Alexion is bracing for the patent expiry of its blockbuster Soliris (eculizumab), used to treat paroxysmal nocturnal haemoglobinuria (PNH) and myasthenia gravis, which hit revenues of around $3bn in 2018. ... The world’s biggest selling drug, Humira,

  • Relearning launch: Four key dynamics for pharma launches in 2019 Relearning launch: Four key dynamics for pharma launches in 2019

    A new cliff is looming: Between 2018 and 2025, branded drugs worth more than $250bn in sales will see their patents expire.

  • Is China ready for a pharmaceutical gold rush?

    A lack of clear patent rules and regulatory transparency, as well as large-scale drug counterfeiting, gave rise to the perception that China’s market was difficult to navigate.

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    This saw phase 3 flops of drugs for stroke, prostate cancer and depression – failures that dented confidence in the firm as patent expiries for its blockbusters Crestor and Nexium loomed on ... revenue growth after years of patent-expiry-induced decline

More from intelligence
Approximately 2 fully matching, plus 112 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 36 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Fearless Girl cover
25 Women Leaders in UK Healthcare
Women trailblazers helping to shape the future of healthcare (Part 1)...
Fearless Girl cover
25 women leaders in UK healthcare (part 2)
...
Curb your enthusiasm (if you want to impress)
How do you build trust in pharmaceutical marketing? Through what you say, not by how loud you shout....

Infographics